# Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)

> **NCT04135937** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 12 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- Smoking

## Interventions

- **DRUG:** Bupropion
- **DRUG:** Varenicline
- **BEHAVIORAL:** Cognitive Behavioral Therapy
- **DRUG:** Nicotine Replacement Therapy
- **BEHAVIORAL:** Relapse Prevention Text Messaging

## Key facts

- **NCT ID:** NCT04135937
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-18
- **Primary completion:** 2021-07-15
- **Final completion:** 2021-11-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135937, "Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04135937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*